UPDATED May 28, 2024
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
ARES | US$144.34 | 0.5% | 65.2% | US$45.2b | US$152.17 | PE65.3x | E42.1% | 2.6% | Diversified Financials | ||
NVDA | US$1,148.25 | 20.9% | 203.5% | US$2.8t | US$1,171.21 | PE66.3x | E22.7% | 0.01% | Semiconductors | ||
NU | US$12.18 | 1.3% | 80.4% | US$56.1b | US$12.46 | PB8.6x | E37.8% | n/a | Banks | ||
SGEN | US$228.74 | 4.5% | 76.5% | US$43.2b | US$228.91 | PS18.8x | E71.8% | n/a | Pharmaceuticals & Biotech | ||
PDD | US$151.27 | 2.8% | 131.6% | US$207.9b | US$203.30 | PE19.1x | E23.2% | n/a | Retail | ||
CG | US$41.73 | -4.5% | 52.2% | US$15.5b | US$48.47 | PS6.8x | E23.6% | 3.4% | Diversified Financials | ||
SMCI | US$839.72 | -3.8% | 275.0% | US$51.2b | US$1,032.47 | PE46.9x | E40.2% | n/a | Tech | ||
SYM | US$41.31 | -5.1% | 10.0% | US$23.9b | US$56.64 | PS2.8x | E128.1% | n/a | Capital Goods | ||
OWL | US$19.23 | 1.7% | 87.6% | US$27.9b | US$21.50 | PE140.8x | E90.8% | 3.7% | Diversified Financials | ||
CELH | US$79.81 | -14.6% | 90.7% | US$19.3b | US$90.35 | PE86.4x | E21.8% | n/a | Food, Beverage & Tobacco | ||
ELF | US$193.24 | 21.6% | 84.2% | US$10.7b | US$203.54 | PE84.7x | E26.3% | n/a | Household | ||
ONON | US$41.82 | 12.1% | 53.1% | US$12.8b | US$38.77 | PE96x | E27.0% | n/a | Consumer Durables | ||
TER | US$145.23 | 3.5% | 41.4% | US$22.5b | US$126.33 | PE52.8x | E23.6% | 0.3% | Semiconductors | ||
PTC | US$177.31 | -3.5% | 31.9% | US$21.5b | US$203.57 | PE73.8x | E22.9% | n/a | Software | ||
CHK | US$89.33 | -0.5% | 18.7% | US$11.9b | US$104.72 | PE11.1x | E35.3% | 2.7% | Energy | ||
ALNY | US$146.93 | -2.6% | -20.6% | US$19.0b | US$220.38 | PS9.3x | E64.2% | n/a | Pharmaceuticals & Biotech | ||
SRPT | US$116.25 | -9.4% | -5.9% | US$10.7b | US$167.47 | PE650.3x | E35.6% | n/a | Pharmaceuticals & Biotech | ||
VRT | US$103.21 | 3.1% | 434.8% | US$39.4b | US$101.72 | PE95.6x | E30.3% | 0.1% | Capital Goods | ||
RYAN | US$54.13 | -2.5% | 32.7% | US$14.1b | US$58.00 | PE101.3x | E76.5% | 0.8% | Insurance | ||
SPOT | US$307.52 | 2.9% | 106.5% | US$61.5b | US$341.47 | PS4.1x | E40.4% | n/a | Media | ||
FTI | US$26.28 | -1.2% | 88.9% | US$11.1b | US$28.49 | PE63.1x | E28.8% | 0.8% | Energy | ||
TEAM | US$165.76 | -5.2% | -8.3% | US$42.9b | US$240.61 | PS10.4x | E41.3% | n/a | Software | ||
HUBS | US$648.23 | 5.8% | 25.1% | US$32.5b | US$673.75 | PS14.5x | E52.4% | n/a | Software | ||
CRWD | US$349.52 | 1.2% | 118.3% | US$83.9b | US$399.05 | PE946.4x | E35.5% | n/a | Software |